TECH bio-techne.com: Multiplikator Forward P/S

Bio-Techne Corporation (TECH) benefits from the conservative approach of scientists when selecting reagents, although the fierce competition for innovation demands colossal R&D expenditures. The forward P/S multiple timeline on the GURU.Markets chart captures this balance, with the value stabilizing at 4.40. The superior purity of its products provides the company with pricing power, allowing it to consistently index product costs without a loss in demand.

bio-techne.com - Rasio kapitalisasi marang dodolan sing dikarepake TECH (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Bio-Techne Inc. (TECH)

- rega saiki lan proyeksi nilai saham:

Rega saham Bio-Techne|TECH - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Kapitalisasi pasar Bio-Techne Inc.|TECH - Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham Bio-Techne|TECH - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku bio-techne.com|TECH - Gunggung Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

- rincian asil keuangan lan kelipatan valuasi:

TECH - Bathi resik taunan|Bathi mangsa ngarep Bio-Techne Corporation|TECH - Pangali P/E|Pangali Forward P/E Techne Corporation|TECH - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Bio-Techne Inc.|TECH - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Bio-Techne|TECH - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan bio-techne.com|TECH - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Bio-Techne Corporation

- indikator volume dodolan lan pendapatan:

TECH - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Bio-Techne|TECH - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Bio-Techne Inc.

Ringkesan analitik perusahaan:Bio-Techne (TECH)

An investment audit of Bio-Techne Corporation (TECH) requires an analysis of the forward P/S ratio, which compares current market capitalization with projected sales volume to assess the premium paid for future growth. Given its monopoly position in the high-purity reagents segment and its pricing power, this forward price-to-sales ratio on GURU.Markets serves as an indicator of the premium's resilience relative to the business's fundamental metrics.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|BRKR - Rasio kapitalisasi marang dodolan sing dikarepake|AZTA (Azenta) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Varex Imaging Corp (VREX)|Multiplikator Forward P/S SMLR|Multiplikator Forward P/S Butterfly Corp (BFLY)|Rasio rega marang prakiraan pendapatan Mesa Laboratories, Inc. MLAB|quantum-si.com - Rasio rega marang prakiraan pendapatan|NNOX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTRX (Quanterix Corp.)|MASS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CapsoVision (CV)|Rasio rega marang prakiraan pendapatan MaxCyte, Inc.|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)